Title: Drug safety evaluation of certolizumab pegol
Authors: Ferrante, Marc ×
Vermeire, Severine
Rutgeerts, Paul #
Issue Date: Feb-2014
Publisher: Informa Healthcare
Series Title: Expert Opinion on Drug Safety vol:13 issue:2 pages:255-266
Article number: 10.1517/14740338.2014.851666
Abstract: The introduction of antibodies directed against tumor necrosis factor (anti-TNF) has dramatically changed our concept of treating both patients with Crohn's disease (CD) and patients with rheumatoid arthritis (RA). Subcutaneous injections with certolizumab pegol (CZP) have been shown efficacious for both CD and RA. In this review, the authors focus on the safety of CZP among other anti-TNF agents.
ISSN: 1474-0338
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Translational Research in GastroIntestinal Disorders
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science